Technology area: Biotechnology & Pharmaceuticals
65 pending office actions • 47 art units • 58 examiners • 0 of 65 (0%) have an AI response strategy ready • 43 patents granted in the last 365 days
University of Virginia Patent Foundation has 64 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 58 distinct examiners and 47 distinct art units, reflecting a large and widely distributed prosecution portfolio. The difference between total actions and examiner assignments indicates that some examiners handle more than one matter, while the broader art-unit spread points to varied technical examination contexts.
WEARE, MEREDITH H is the busiest examiner, with 3 pending matters. That docket is a useful starting point for identifying repeated prosecution themes, although it does not represent the entire portfolio. Counsel will need both centralized oversight for common biotechnology claim issues and matter-specific analysis for the many examiner and art-unit combinations.
Based on the USPTO statutory response window for each pending office action. 22 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 22 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 3 (5%) |
| §101 + other | 10 (15%) |
| §103 only | 19 (29%) |
| §102 only | 1 (2%) |
| §112 only | 5 (8%) |
| Double-patenting + other | 1 (2%) |
| Multi-statute (no §101) | 23 (35%) |
| No statute on record | 3 (5%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WEARE, MEREDITH H | 4 | 50.5% | +31.4% |
| LIPPERT, JOHN WILLIAM | 2 | 59.2% | +39.9% |
| LUO, JAMMY NMN | 2 | — | — |
| HUDSON, AMY ROSE | 2 | 74.8% | +11.7% |
| SHUPE, ELIZABETH A | 2 | 65.8% | +45.5% |
| DUDEK JR, EDWARD J | 1 | 89.2% | +5.4% |
| DALLO, JOSEPH J | 1 | 89.8% | +7.0% |
| STEPHENS, REBECCA JOHANNA | 1 | 68.2% | +27.7% |
| TRAN, THANG DUC | 1 | 76.3% | +23.1% |
| ROBINSON, NICHOLAS A | 1 | 48.4% | +55.0% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19233680 | MEMBRANE: ACCELERATING DATABASE ANALYTICS WITH DRAM-PIM FILTERING | DUDEK JR, EDWARD J | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17637557 | DDX17 AND NLRC4 TARGETING FOR INFLAMMATORY DISEASES | GOMEZ RODRIGUEZ, JULIO WASHINGTON | 162d overdue |
| 18316981 | COMPOSITIONS AND METHODS FOR TREATING AGE-RELATED MACULAR DEGENERATION AND GEOGRAPHIC ATROPHY | HUDSON, AMY ROSE | 127d overdue |
| 17407604 | Cardiac Muscle-Cell-Based Coupled Oscillator Network for Collective Computing and Related Methods | CORDAS, EMILY ANN | 36d overdue |
| 18573382 | System, Method and Computer Readable Medium for Determining Characteristics Of Surgical Related Items and Procedure Related Items Present for Use in the Perioperative Period | WILLIAMS, REBECCA COLETTE | 19d overdue |
| 17629303 | CYSTEINE BINDING COMPOSITIONS AND METHODS OF USE THEREOF | JARRELL, NOBLE E | 8d overdue |
| 18011412 | TYPE 2 CYTOKINES AS PREDICTORS OF DISEASE SEVERITY AND/OR AS THERAPEUTIC TARGETS FOR COVID-19 | KIM, YUNSOO | 1d overdue |
| 17909170 | SYSTEM AND METHOD FOR PREDICTING RISK OF DIAGNOSIS FOR AUTISM SPECTRUM DISORDER USING NEONATAL ANALYTICS | ROBINSON, GRETA LEE | 20d |
| 18500403 | SYSTEM AND METHOD FOR DETECTING SENSOR COMPRESSION OF CONTINUOUS GLUCOSE MONITORING (CGM) SENSORS | SHAH, JAY B | 29d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18316981 | COMPOSITIONS AND METHODS FOR TREATING AGE-RELATED MACULAR DEGENERATION AND GEOGRAPHIC ATROPHY | HUDSON, AMY ROSE | 127d overdue |
| 18037684 | MULTICOMPARTMENT CONDUCTIVE COLLAGEN SCAFFOLD AND RELATED METHODS OF MAKING AND USING THE SAME | LIPPERT, JOHN WILLIAM | 89d overdue |
| 17050231 | COMPOSITIONS AND METHODS FOR TREATING ABDOMINAL AORTIC ANEURYSM | SHUPE, ELIZABETH A | 89d overdue |
| 18500212 | SYSTEM AND METHOD FOR DETECTING PRESSURE INDUCED SENSOR ATTENUATIONS (PISAs) OF CONTINUOUS GLUCOSE MONITORING (CGM) | WEARE, MEREDITH H | 60d |
| 19225122 | TISSUE-SPECIFIC PROMOTERS IN PLANTS | STEPHENS, REBECCA JOHANNA | — |
| 19109729 | VIBRATION BASED INTERACTION SYSTEM FOR ON BODY DEVICE AND METHOD | TRAN, THANG DUC | — |
| 19108271 | SYSTEM AND METHOD FOR BODY MOTOR FUNCTION ASSESSMENT | ROBINSON, NICHOLAS A | — |
| 18931879 | SYSTEM COORDINATOR AND MODULAR ARCHITECTURE FOR OPEN-LOOP AND CLOSED-LOOP CONTROL OF DIABETES | WEARE, MEREDITH H | — |
| Art Unit | Apps |
|---|---|
| 3791 | 5 |
| 1632 | 4 |
| 1615 | 3 |
| 1686 | 3 |
| 3798 | 2 |
| 1645 | 2 |
| 1699 | 2 |
| 1636 | 2 |
| 1643 | 2 |
| 1677 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19233680 | MEMBRANE: ACCELERATING DATABASE ANALYTICS WITH DRAM-PIM FILTERING | DUDEK JR, EDWARD J | 2139 | §103 | Non-Final OA | — | Pending | Jun 10, 2025 |
| 19230408 | VEHICLES AND METHODS FOR VEHICLE IMPACT MITIGATION | DALLO, JOSEPH J | 3661 | §102§103 | Non-Final OA | — | Pending | Jun 06, 2025 |
| 19225122 | TISSUE-SPECIFIC PROMOTERS IN PLANTS | STEPHENS, REBECCA JOHANNA | 1663 | §102§112DP | Non-Final OA | — | Pending | Jun 02, 2025 |
| 19109729 | VIBRATION BASED INTERACTION SYSTEM FOR ON BODY DEVICE AND METHOD | TRAN, THANG DUC | 2686 | §103 | Non-Final OA | — | Pending | Mar 07, 2025 |
| 19108271 | SYSTEM AND METHOD FOR BODY MOTOR FUNCTION ASSESSMENT | ROBINSON, NICHOLAS A | 3798 | §102§103§112 | Non-Final OA | — | Pending | Mar 03, 2025 |
| 19006155 | CLASSIFICATION OF INSTERSTITIAL LUNG DISEASE | CHNG, JOY POH AI | 3686 | §101 | Non-Final OA | — | Pending | Dec 30, 2024 |
| 18874464 | MIXED LINKAGE GLUCAN BIOSYNTHESIS BY CELLULOSE SYNTHASE-LIKE CSLF6 (1,3;1,4)-B-GLUCAN SYNTHASE | DEVEAU ROSEN, JASON | 1662 | §112 | Final Rejection | — | Pending | Dec 12, 2024 |
| 18870862 | SYSTEM, METHOD, AND COMPUTER READABLE MEDIUM FOR CGM-BASED OGTT REPLACEMENT DIAGNOSIS TEST | TIEDEMAN, JASON S | 3683 | §101§103§112 | Non-Final OA | — | Pending | Dec 02, 2024 |
| 18862887 | MEASUREMENT OF PERMEATION OF SMALL MOLECULES INTO GRAM NEGATIVE BACTERIA | GOUGH, TIFFANY MAUREEN | 1651 | §103 | Non-Final OA | — | Pending | Nov 04, 2024 |
| 18931879 | SYSTEM COORDINATOR AND MODULAR ARCHITECTURE FOR OPEN-LOOP AND CLOSED-LOOP CONTROL OF DIABETES | WEARE, MEREDITH H | 3791 | §101§103Other | Non-Final OA | — | Pending | Oct 30, 2024 |
| 18854483 | AUTOMATION OF THE BLOOD INPUT FUNCTION COMPUTATION PIPELINE FOR DYNAMIC FDG PET FOR HUMAN BRAIN USING MACHINE LEARNING | DANG, RACHEL YEN VI | 2668 | §103 | Non-Final OA | — | Pending | Oct 04, 2024 |
| 18852262 | SYSTEMS AND METHODS UTILIZING THERANOSTIC AGENTS FOR BPCT AND BNCT FOR TARGETED CANCER TREATMENT | LIPPERT, JOHN WILLIAM | 1615 | §103 | Non-Final OA | — | Pending | Sep 27, 2024 |
| 18844280 | INHIBITORS OF FLI1 AND ERG | CHAO, ALLEN | 1622 | §112 | Non-Final OA | — | Pending | Sep 05, 2024 |
| 18811413 | STEADY-STATE THERMO-REFLECTANCE METHOD & SYSTEM TO MEASURE THERMAL CONDUCTIVITY | JAGAN, MIRELLYS | 2855 | §112 | Non-Final OA | — | Pending | Aug 21, 2024 |
| 18642539 | NANOFIBERS AND THEIR USE IN ENHANCING PARTICLE-BASED HYDROGEL SCAFFOLDS FOR REGENERATIVE MEDICINE AND TISSUE ENGINEERING | BROWE, DAVID | 1632 | §103§112 | Non-Final OA | — | Pending | Apr 22, 2024 |
| 18692937 | METHODS FOR TREATING NEUROINFLAMMATION | CHEONG, CHEOM-GIL | 1645 | §102§103§112 | Non-Final OA | — | Pending | Mar 18, 2024 |
| 18604185 | ANNEXIN TO INHIBIT BACTERIA | NIEBAUER, RONALD T | 1658 | §102§112 | Non-Final OA | — | Pending | Mar 13, 2024 |
| 18685194 | SULFONYL-TRIAZOLES USEFUL AS COVALENT KINASE LIGANDS | MOORE, SUSANNA | 1624 | §102§112 | Final Rejection | — | Pending | Feb 20, 2024 |
| 18684813 | SYSTEMS, METHODS, AND COMPUTER READABLE MEDIA FOR PARAMETRIC FDG PET QUANTIFICATION, SEGMENTATION AND CLASSIFICATION OF ABNORMALITIES | FANG, MICHAEL YIMING | 3798 | §103 | Non-Final OA | 92d overdue | Pending | Feb 19, 2024 |
| 18684122 | SINTERED MANGANESE SPINEL BATTERY ELECTRODES | HORNSBY, BARTHOLOMEW ANDREW | 1728 | §103§112 | Non-Final OA | — | Pending | Feb 15, 2024 |
| 18428746 | METHODS OF TREATING VASCULAR MALFORMATIONS | BARHAM, BETHANY P | 1611 | §102§103Other | Non-Final OA | — | Pending | Jan 31, 2024 |
| 18573382 | System, Method and Computer Readable Medium for Determining Characteristics Of Surgical Related Items and Procedure Related Items Present for Use in the Perioperative Period | WILLIAMS, REBECCA COLETTE | 2677 | §101§103 | Final Rejection | 19d overdue | Pending | Dec 21, 2023 |
| 18390081 | SYSTEM COORDINATOR AND MODULAR ARCHITECTURE FOR OPEN-LOOP AND CLOSED-LOOP CONTROL OF DIABETES | WEARE, MEREDITH H | 3791 | §101§103 | Final Rejection | — | Pending | Dec 20, 2023 |
| 18542104 | COMPOSITION AND METHOD FOR A MICROTEXTURE HYDROPHOBIC OR SUPERHYDROPHOBIC COATING | MANGOHIG, THOMAS A | 1788 | §103 | Final Rejection | 120d overdue | Pending | Dec 15, 2023 |
| 18566497 | MINICELLS FROM HIGHLY GENOME REDUCED ESCHERICHIA COLI: CYTOPLASMIC AND SURFACE EXPRESSION OF RECOMBINANT PROTEINS AND INCORPORATION IN THE MINICELLS | GANGLE, BRIAN J | 1645 | §112 | Final Rejection | 15d | Pending | Dec 01, 2023 |
| 18500212 | SYSTEM AND METHOD FOR DETECTING PRESSURE INDUCED SENSOR ATTENUATIONS (PISAs) OF CONTINUOUS GLUCOSE MONITORING (CGM) | WEARE, MEREDITH H | 3791 | §101§102§103 | Final Rejection | 60d | Pending | Nov 02, 2023 |
| 18500403 | SYSTEM AND METHOD FOR DETECTING SENSOR COMPRESSION OF CONTINUOUS GLUCOSE MONITORING (CGM) SENSORS | SHAH, JAY B | 3791 | §101 | Final Rejection | 29d | Pending | Nov 02, 2023 |
| 18495324 | SYSTEM AND METHOD FOR GAUSSIAN PROCESS AND DEEP LEARNING ATMOSPHERIC CORRECTION | ROZ, MARK | 2675 | — | Final Rejection | — | Pending | Oct 26, 2023 |
| 18284962 | STABILIZED BORON ANIONS | CARR, DEBORAH D | 1691 | §102§103§112 | Non-Final OA | — | Pending | Sep 29, 2023 |
| 18472215 | Methods and Systems for Intramyocardial Tissue Displacement and Motion Measurement | THOMAS, SOUMYA | 2664 | §103Other | Non-Final OA | — | Pending | Sep 21, 2023 |
| 18278549 | METHOD AND SYSTEM FOR QUANTITATIVE PHYSIOLOGICAL ASSESSMENT AND PREDICTION OF CLINICAL SUBTYPES OF GLUCOSE METABOLISM DISORDERS | LUO, JAMMY NMN | 1686 | §101§103§112 | Non-Final OA | — | Pending | Aug 23, 2023 |
| 18278485 | METHOD AND SYSTEM FOR MAPPING INDIVIDUALIZED METABOLIC PHENOTYPE TO A DATABASE IMAGE FOR OPTIMIZING CONTROL OF CHRONIC METABOLIC CONDITIONS | LUO, JAMMY NMN | 1686 | §101§103 | Non-Final OA | — | Pending | Aug 23, 2023 |
| 18277752 | THE COMBINED INFLUENCE OF VISCOELASTIC AND ADHESIVE CUES ON FIBROBLAST SPREADING AND FOCAL ADHESION FORMATION | LEE, DORIS L | 1699 | §102 | Non-Final OA | — | Pending | Aug 17, 2023 |
| 18264347 | PARTICLES FUNCTIONALIZED WITH THERAPEUTIC RADIOISOTOPES AND METHODS OF MAKING AND USE THEREOF | RONEY, CELESTE A | 1612 | Other | Final Rejection | 11d overdue | Pending | Aug 04, 2023 |
| 18271911 | ADRENERGIC MECHANISMS OF AUDIOGENIC SEIZURE-INDUCED DEATH IN MOUSE MODEL OF SCN8A ENCEPHALOPATHY | SCHULTZ, JAMES | 1631 | §103 | Non-Final OA | — | Pending | Jul 12, 2023 |
| 18333955 | SYSTEM COORDINATOR AND MODULAR ARCHITECTURE FOR OPEN-LOOP AND CLOSED-LOOP CONTROL OF DIABETES | WEARE, MEREDITH H | 3791 | §103§112 | Non-Final OA | — | Pending | Jun 13, 2023 |
| 18037684 | MULTICOMPARTMENT CONDUCTIVE COLLAGEN SCAFFOLD AND RELATED METHODS OF MAKING AND USING THE SAME | LIPPERT, JOHN WILLIAM | 1615 | §103 | Final Rejection | 89d overdue | Pending | May 18, 2023 |
| 18316981 | COMPOSITIONS AND METHODS FOR TREATING AGE-RELATED MACULAR DEGENERATION AND GEOGRAPHIC ATROPHY | HUDSON, AMY ROSE | 1636 | §103§112 | Final Rejection | 127d overdue | Pending | May 12, 2023 |
| 18306680 | THERAPEUTIC TARGETING OF ACTIVATED AVIL-INDUCED SARCOMAS | HUDSON, AMY ROSE | 1636 | §103§112 | Final Rejection | — | Pending | Apr 25, 2023 |
| 18031969 | COMPOSITIONS AND METHODS FOR OVERCOMING DR5-INDUCED IMMUNE EVASION BY SOLID TUMORS | SHUPE, ELIZABETH A | 1643 | §103§112 | Final Rejection | — | Pending | Apr 14, 2023 |
| 18246372 | METHOD AND SYSTEM FOR EARLY EFFICIENT DETECTION OF CO-EVOLUTIONARY SITES IN EVOLVING BIO-NETWORKS | LI, SUN M | 3685 | §101 | Non-Final OA | — | Pending | Mar 23, 2023 |
| 18027202 | 3D-PRINTED MODULAR MICROCHIP WITH AN INTEGRATED IMPELLER PUMP TO MODEL INTER-ORGAN COMMUNICATION | GIERE, REBECCA M | 1677 | §103 | Non-Final OA | 5d overdue | Pending | Mar 20, 2023 |
| 18018848 | ULTRASOFT, STRETCHABLE, REVERSIBLE ELASTOMERS FOR DIRECT-WRITE PRINTING DEFORMABLE STRUCTURES | RODD, CHRISTOPHER M | 1766 | §102§103§112 | Non-Final OA | — | Pending | Jan 30, 2023 |
| 18014726 | HERMETICALLY OR ASEPTICALLY SEALED BIOREACTOR SYSTEM AND RELATED METHOD THEREOF | KIPOUROS, HOLLY MICHAELA | 1799 | §103 | Final Rejection | 38d overdue | Pending | Jan 05, 2023 |
| 18011412 | TYPE 2 CYTOKINES AS PREDICTORS OF DISEASE SEVERITY AND/OR AS THERAPEUTIC TARGETS FOR COVID-19 | KIM, YUNSOO | 1641 | §102§103Other | Non-Final OA | 1d overdue | Pending | Dec 19, 2022 |
| 17910613 | METABOLITES RELEASED FROM APOPTOTIC CELLS ACT AS NOVEL TISSUE MESSENGERS | BARSKY, JARED | 1628 | §103 | Final Rejection | 78d overdue | Pending | Sep 09, 2022 |
| 17909170 | SYSTEM AND METHOD FOR PREDICTING RISK OF DIAGNOSIS FOR AUTISM SPECTRUM DISORDER USING NEONATAL ANALYTICS | ROBINSON, GRETA LEE | 2163 | §103§112 | Final Rejection | 20d | Pending | Sep 02, 2022 |
| 17800387 | CAR T CELLS TARGETING THE INTEGRIN ALPHAV BETA3 EXHIBIT ROBUST ANTI-TUMOR RESPONSES AGAINST GLIOMAS AND OTHER SOLID TUMOR MALIGNANCIES | BELYAVSKYI, MICHAIL A | 1644 | §103 | Final Rejection | — | Pending | Aug 17, 2022 |
| 17800371 | AAV-Mediated Targeting of MIRNA in the Treatment of X-Linked Disorders | TRAN, CHRISTINA L | 1637 | §103§112 | Non-Final OA | — | Pending | Aug 17, 2022 |
| 17796203 | MITIGATING CONCENTRATION EFFECTS OF ANTIBODY DIGESTION FOR COMPLETE SEQUENCE COVERAGE | COOK, LISA V | 1642 | §103§112 | Non-Final OA | — | Pending | Jul 28, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialUniversity of Virginia Patent Foundation has 65 pending office actions as of October 2026, spread across 47 art units and 58 examiners.
Meredith H Weare has the most, with 4 of University of Virginia Patent Foundation's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
